VISTAGEN THERAPEUTICS, INC. Increase (Decrease) in Deferred Charges
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Increase (Decrease) in Deferred Charges of $0 for the 12-month period ending 2020-03-31, per its 10-K filed 2020-06-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2020-06-29
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2018-09-30 was -$141.60K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2018-06-30 was $13.60K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2018-03-31 was -$306.20K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2017-12-31 was $333.40K, a 765.97% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2020 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2019 was -$90.50K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2018 was -$146.30K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2015 was $14.40K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 3 month as first filed | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 6 month as first filed | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|---|---|
| 2020-03-31 | $0.00 10-K · filed 2020-06-29 | |||||
| 2019-03-31 | -$90.50K 10-K · filed 2020-06-29 | |||||
| 2018-09-30 | -$141.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-29 | -$128.00K 10-Q · filed 2018-10-29 | -$434.20K derived: sum of 3 quarters · filed 2019-06-25 | -$100.80K derived: sum of 4 quarters · filed 2019-06-25 | ||
| 2018-06-30 | $13.60K 10-Q · filed 2018-08-14 | -$292.60K derived: sum of 2 quarters · filed 2019-06-25 | $40.80K derived: sum of 3 quarters · filed 2019-06-25 | -$69.40K derived: sum of 4 quarters · filed 2019-06-25 | ||
| 2018-03-31 | -$306.20K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-25 | $27.20K derived: sum of 2 quarters · filed 2019-06-25 | -$83.00K derived: sum of 3 quarters · filed 2019-06-25 | -$146.30K 10-K · filed 2019-06-25 | ||
| 2017-12-31 | $333.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-12 | $223.20K derived: sum of 2 quarters · filed 2018-10-29 | $159.90K 10-Q · filed 2018-02-12 | |||
| 2017-09-30 | -$110.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-29 | -$173.50K 10-Q · filed 2018-10-29 | $173.50K 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | -$63.30K 10-Q · filed 2018-08-14 | $63.30K 10-Q · filed 2017-08-14 | ||||
| 2016-12-31 | $38.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-12 | $28.30K derived: sum of 2 quarters · filed 2018-02-12 | $20.40K 10-Q · filed 2018-02-12 | |||
| 2016-09-30 | -$10.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | -$18.10K 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | -$7.90K 10-Q · filed 2017-08-14 | |||||
| 2015-12-31 | -$7.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-13 | -$14.80K derived: sum of 2 quarters · filed 2017-02-13 | -$19.50K 10-Q · filed 2017-02-13 | $4.60K derived: sum of 4 quarters · filed 2017-02-13 | ||
| 2015-09-30 | -$6.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | -$11.60K 10-Q · filed 2016-11-14 | $12.50K derived: sum of 3 quarters · filed 2016-11-14 | $7.80K derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | -$4.70K 10-Q · filed 2016-08-12 | $4.70K 10-Q · filed 2015-08-14 | $19.40K derived: sum of 2 quarters · filed 2016-08-12 | $14.70K derived: sum of 3 quarters · filed 2016-08-12 | $8.30K derived: sum of 4 quarters · filed 2016-08-12 | |
| 2015-03-31 | $24.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29 | $19.40K derived: sum of 2 quarters · filed 2016-02-16 | $13.00K derived: sum of 3 quarters · filed 2016-02-16 | $14.40K 10-K · filed 2015-06-29 | ||
| 2014-12-31 | -$4.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | -$11.10K derived: sum of 2 quarters · filed 2016-02-16 | -$9.70K 10-Q · filed 2016-02-16 | |||
| 2014-09-30 | -$6.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16 | -$5.00K 10-Q · filed 2015-11-16 | ||||
| 2014-06-30 | $1.40K 10-Q · filed 2015-08-14 | |||||
| 2014-03-31 | -$56.80K 10-K · filed 2015-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |